Archive

July 2024

• 26: EBNEO COMMENTARY: Surfactant administration via laryngeal mask airway versus brief tracheal intubation in preterm infants. (0)
• 25: EBNEO COMMENTARY: Nutritional Support for Moderate-to-Late-Preterm Infants (0)
• 14: EBNEO Commentary: The impact of timing of inguinal hernia repair on outcomes in preterm infants (0)

April 2024

• 20: EBNEO Commentary: Patent Ductus Arteriosus (PDA)-To treat early or not with ibuprofen? (2)

February 2024

• 24: EBNEO Commentary: Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan (0)
• 24: EBNEO COMMENTARY: REDUCING EXTUBATION FAILURE IN EXTREME PRETERM INFANTS – HIGHER VS STANDARD nCPAP (0)

January 2024

• 09: EBNEO Commentary: De-MIST-ifying the two-year outcomes of non-invasive surfactant therapy (0)
• 06: EBNEO Commentary: Umbrella Review Evaluating Interventions to Decrease Risk of Bronchopulmonary Dysplasia in Preterm Neonates (0)
• 06: EBNEO Commentary: Early Human Milk Fortification in Infants Born Extremely Preterm: A Randomized Trial (0)
• 06: EBNEO Commentary: Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial (0)

December 2023

• 21: EBNEO Commentary: Noninvasive High-Frequency Oscillatory Ventilation vs Nasal Continuous Positive Airway Pressure vs Nasal Intermittent Positive Pressure Ventilation as Postextubation Support for Preterm Neonates (0)

November 2023

• 01: EBNEO Commentary: Safety and Immunogenicity of GBS Vaccine in Pregnancy and Determination of a Serocorrelate for Infant Protection (0)

September 2023

• 11: EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD? (0)

August 2023

• 10: EBNEO Commentary: Respiratory syncytial virus vaccine in pregnancy for infant protection (0)

July 2023

• 11: EBNEO Commentary: Interventions to Reduce Severe Brain Injury Risk in Preterm Neonates: A Systematic Review and Meta-analysis (1)
• 05: EBNEO COMMENTARY: DEXMEDETOMIDINE FOR THE MANAGEMENT OF POSTOPERATIVE PAIN AND SEDATION IN NEWBORNS (0)

May 2023

• 17: EBNEO COMMENTARY: Precision management of the patent ductus arteriosus in micropreemies (0)
• 02: EBNEO COMMENTARY: Prediction of Extubation Failure among Low Birthweight Neonates using Machine Learning (0)

April 2023

• 19: EBNEO COMMENTARY: Platelet transfusions in neonates and brain development: the new frontier (0)
• 19: EBNEO COMMENTARY: Dextrose gel for neonates at risk with asymptomatic hypoglycemia: a randomized clinical trial (0)
• 19: EBNEO COMMENTARY: Weaning from cpap using high-flow is non-inferior to using cpap alone in very preterm infants (0)
• 18: EBNEO COMMENTARY: Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus (0)

March 2023

• 21: EBNEO Commentary: Long-Term Outcome of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation (0)
• 21: EBNEO Commentary: Early Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years (0)
• 15: EBNEO Commentary: Long-Term Outcomes following Necrotizing Enterocolitis and Spontaneous Intestinal Perforation (0)
• 09: EBNEO Commentary: Fluid Balance as a Critical Factor in Neonatal Outcomes (0)

February 2023

• 14: EBNEO Commentary: Oral versus intravenous sildenafil for pulmonary hypertension in late preterm and term infants (0)
• 01: EBNEO Commentary: Maternal high-dose DHA supplementation and neurodevelopment in infants born before 29 weeks’ gestation

January 2023

• 20: EBNEO COMMENTARY: Safety and Efficacy of Erythropoietin in neonates with Hypoxic-Ischaemic Encephalopathy.

December 2022

• 21: Early Switching from Intravenous to Oral Antibiotics in Neonates with Probable Bacterial Infection
• 13: EBNEO COMMENTARY: NASAL HIGH-FLOW THERAPY DURING NEONATAL ENDOTRACHEAL INTUBATION

November 2022

• 30: EBNEO Commentary: Umbilical cord milking in nonvigorous infants: a cluster-randomized crossover trial

October 2022

• 05: EBNEO Commentary: Need to further study levetiracetam as first-line drug for neonatal convulsions

August 2022

• 16: EBNEO Commentary: Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia (1)

July 2022

• 29: EBNEO Commentary: ASSOCIATION BETWEEN SEIZURES DURING REWARMING AFTER HYPOTHERMIA FOR NEONATAL HYPOXIC ISCHEMIC ENCEPHALOPATHY AND ABNORMAL NEURODEVELOPMENTAL OUTCOMES

June 2022

• 30: EBNEO Commentary: Antenatal Corticosteroids for Late Preterm Gestation in Low-Resource Countries
• 29: EBNEO Commentary: Efficacy and Safety of Enteral Recombinant Human Insulin in Preterm Infants: A Randomized Clinical Trial
• 14: EBNEO Commentary: Outcomes following preterm birth: what we think and what is real

May 2022

• 17: Elevated Depression and Anxiety Symptoms in Parents of Very Preterm Infants While Hospitalized and Post-discharge
• 13: EBNEO Commentary: Dexmedetomidine versus morphine for neonates with encephalopathy undergoing therapeutic hypothermia.

March 2022

• 14: Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial

February 2022

• 14: RANDOMISED CONTROLLED TRIAL OF HELIOX IN NEWBORN INFANTS WITH MECONIUM ASPIRATION SYNDROME
• 14: Fetal Surgery for Severe Left Diaphragmatic Hernia

January 2022

• 14: OPTIMIST-ically moving towards targeted non-invasive surfactant therapy?
• 14: Does azithromycin eradicate Ureaplasma in preterm infants?
• 14: Antenatal Dexamethasone Reduces Mortality in Preterm Infants in Low Resource Countries
• 13: Interventions to support parents of infants at risk or with a diagnosis of neurodevelopmental disability
• 13: A Randomized Trial of Laryngeal Mask Airway in Neonatal Resuscitation
• 13: IS INTRAVENOUS PARACETAMOL AS EFFECTIVE AS IBUPROFEN IN CLOSING HEMODYNAMICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS AFTER THE FIRST TREATMENT COURSE IN PRETERM BABIES? (1)
• 13: Can Spontaneous Breathing Trials Help Assess Extubation Readiness in Extremely Preterm Neonates?
• 13: A network meta-analysis of postnatal corticosteroids for bronchopulmonary dysplasia: has the most appropriate treatment been revealed?
• 13: Paracetamol/acetaminophen to avoid PDA ligation: how to interpret impact on 18-24 month outcomes
• 13: Intubation Competence During Neonatal Fellowship Training: A Trainee’s Perspective
• 06: Effect of systematic hydrocortisone initiated 7 to 14 days after birth in ventilated preterm infants on mortality and neurodevelopment at 2 years’ corrected age

December 2021

• 16: Delivery Room Thermal Care Interventions in Preterm Neonates
• 16: Safety of early discontinuation of anti-seizure medication in neonates
• 16: Should We Abandon Therapeutic Hypothermia for Neonatal Encephalopathy in Low and Middle-Income Countries? (1)
• 16: Immediate “Kangaroo Mother Care” and Survival of Infants with Low Birth Weight

September 2021

• 08: Longitudinal antibiotic susceptibilities of neonatal Escherichia coli infection

July 2021

• 13: Changes in PDA Treatment Strategy and Respiratory Outcomes: Optimal Timing and Shunts to Intervene … Continuing the Long Conversation

June 2021

• 15: Red blood cell transfusion thresholds in extremely low birth weight infants II (1)
• 15: REAL-TIME CONTINUOUS GLUCOSE MONITORING IN PRETERM INFANTS (REACT): AN INTERNATIONAL, OPEN-LABEL, RANDOMISED, CONTROLLED TRIAL
• 15: Unravelling the epidemiology and clinical impact of SARS-CoV-2 infection in neonates
• 15: EARLY ONSET SARS-COV-2 INFECTION IN NEONATES BORN TO COVID POSITIVE MOTHERS

April 2021

• 07: Randomized Controlled Trial of High-Flow Nasal Cannula in Preterm Infants After Extubation (1)

March 2021

• 20: Multisensory early intervention can improve visual function in preterm infants at term equivalent age
• 20: Red blood cell transfusion thresholds in extremely low birthweight infants (1)
• 20: COMPARATIVE EFFICACY OF LEVETIRACETAM TO PHENOBARBITAL IN THE TREATMENT OF NEONATAL SEIZURES
• 20: Lung recruitment prior to IN-SUR-E procedure – safe and effective?
• 11: Aerosolized Calfactant in Infants with RDS: a feasible route of surfactant administration?

January 2021

• 27: DOES THE 2-YEAR BEHAVIORAL PROFILE OF CHILDREN BORN EXTREMELY PRETERM CHANGE WITH BRONCHOPULMONARY DYSPLASIA SEVERITY?
• 04: Impact of very preterm birth on maternal employment and socio-economic status

December 2020

• 28: Can a predictive model for extubation readiness in preterm infants improve rates of successful extubation?
• 25: The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants – Which is the Better Definition?
• 22: Interventions to support parents of infants at risk or with a diagnosis of neurodevelopmental disability

November 2020

• 05: Inhaled nitric oxide in managing preterm infants with suspected pulmonary hypoplasia

September 2020

• 22: Early neurodevelopmental screening: Parent perspectives from the Neonatal Intensive Care Unit

August 2020

• 09: Predicting poor physical activity outcomes in children born extremely preterm or extremely low birthweight

July 2020

• 09: How does Family Integrated Care in the NICU affect short-term infant and parent outcomes?

June 2020

• 12: Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia

May 2020

• 18: A Comparison of UK Preterm Anthropometric Charts and INTERGROWTH-21st: Is It Time to Change Growth Charts?

April 2020

• 16: Lower versus Traditional Treatment Threshold for Neonatal Hypoglycemia: No Difference Between the groups at 18 months of Age, Awaiting Long-term Outcomes

March 2020

• 18: Do antimicrobial-impregnated central venous catheters prevent nosocomial bloodstream infection in neonates?
• 14: Ranibizumab – The jury is still out
• 03: Is delayed cord clamping in preterm infants as safe as immediate clamping regarding 2-years outcomes?

February 2020

• 21: Does hydrocortisone reduce death and BPD in preterm infants who remain intubated beyond a week of life?
• 11: Sedation during minimal invasive surfactant treatment

January 2020

• 22: Does topiramate in addition to therapeutic hypothermia reduce seizure burden in infants with hypoxic ischemic encephalopathy compared to therapeutic hypothermia alone?

December 2019

• 22: Does prefeed gastric residual evaluation impair enteral nutrition intake in very preterm infants?
• 22: Early intervention starting in the neonatal nursery to improve child development
• 09: Is early oral vitamin A supplementation useful in preterm neonates at risk for bronchopulmonary dysplasia? (2)

November 2019

• 05: Enteral lactoferrin does not reduce late onset infection in very preterm infants

October 2019

• 05: Improved Feeding Tolerance and Growth Linked to Gut Microbial Diversity in Very-Low-Birth-Weight Infants Fed with Mother’s Own Milk vs. Donor Milk (1)

September 2019

• 04: Quality Improvement Can Reduce Unintended Extubations
• 04: The effects of various platelet-transfusion thresholds in preterm infants with severe thrombocytopenia

August 2019

• 01: Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial

July 2019

• 25: Nasal High-Flow Therapy for Newborn Infants in Special Care Nurseries (2)
• 25: Sustained Lung Inflation Does Not Decrease Bronchopulmonary Dysplasia or Death among Extremely Preterm Infants: The SAIL Randomized Clinical Trial

June 2019

• 14: Does permissive hypercapnia carry increased risk for neurodevelopmental sequelae?
• 11: Morphine versus Methadone in the Treatment of Neonatal Abstinence Syndrome
• 11: Does an Elevated Midline Head Position Prevent Periventricular-Intraventricular Hemorrhage in Extremely Low Birthweight Neonates? (2)

May 2019

• 07: Multiple vital signs analysis algorithm detects systemic inflammatory response in premature infants with late onset sepsis and necrotizing enterocolitis

April 2019

• 24: PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age

March 2019

• 31: Weaning of Moderately Preterm Infants from the Incubator to the Crib: A Randomized Clinical Trial
• 02: The language environment of the hospitalized neonate

February 2019

• 27: Association of Antenatal Steroid Exposure with Survival Among Infants Receiving Postnatal Life Support at 22 to 25 Weeks’ Gestation

January 2019

• 30: Does lung ultrasound score predict the need for surfactant in extremely preterm neonates?
• 26: The effects of labor induction at 39 weeks in low-risk nulliparous women
• 17: Does nebulized surfactant benefit neonates with respiratory distress syndrome on non-invasive respiratory support?
• 02: ROTAVIRUS VACCINE FOR NEONATES

December 2018

• 15: The Ideal Strategy of Weaning from Nasal Continuous Positive Airway Pressure in Preterm Infants: Are We There Yet?
• 11: Preterm Neuroimaging and School-Age Cognitive Outcomes

October 2018

• 25: Growing identification of genetic etiologies for neonatal-onset epilepsies: lessons from the Neonatal Seizure Registry

September 2018

• 12: Does Using a Nasal Barrier Dressing Prevent Nasal Injury in Premature Infants Receiving Nasal Continuous Positive Airway Pressure?
• 08: Does tight glycemic control with insulin therapy in the early neonatal period improve long-term outcomes?

June 2018

• 21: Is paracetamol as effective as indomethacin or ibuprofen in closing a hemodynamically significant patent ductus arteriosus in preterm infants?
• 09: Quality-Improvement Effort to Reduce Hypothermia Among High- Risk Infants on a Mother-Infant Unit
• 03: A Quantitative, Risk-Based Approach to the Management of Neonatal Early-Onset Sepsis
• 03: Late Neuroimaging Predicts Neurodevelopmental Outcomes in Preterm Infants

May 2018

• 17: The effects of music on hospitalized preterm neonates (2)

April 2018

• 07: Does non-invasive ventilation confer a lung protective effect and improve long-term pulmonary outcomes?
• 07: Does late therapeutic hypothermia reduce risk of death or disability?

March 2018

• 19: Annual Reports for 2017

February 2018

• 06: Activity levels of preterm children at seven years of age

January 2018

• 26: Lectures from EBNEO 2017 in Hyderabad, now on Youtube (2)
• 24: Best Review 2017 Contest!
• 11: Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection

December 2017

• 30: Does Erythropoietin monotherapy reduce mortality or moderate/severe disability in neonates with hypoxic ischemic encephalopathy?

November 2017

• 05: Do fidgety general movements predict cerebral palsy and cognitive outcome in clinical follow-up of very preterm infants? (1)
• 05: Shaken or Stirred? Evaluating the combination of budesonide-surfactant for survival free of bronchopulmonary dysplasia (1)
• 05: Does a procalcitonin-guided approach to term and late-preterm neonates with suspected early-onset sepsis safely decrease unnecessary antibiotic exposure?

October 2017

• 25: Antenatal Magnesium for Preterm Delivery Reduces Risk of Cerebral Palsy Among Surviving Very Preterm Infants (3)

September 2017

• 22: Early hydrocortisone improves survival without bronchopulmonary dysplasia in extremely preterm born infants.
• 01: Write an EBNEO review and get published also in Acta Paediatrica

July 2017

• 06: Does a comprehensive family-centred early intervention service affect stress reactivity and emotion regulation in very low birth weight preterm infants at toddler age?

May 2017

• 19: Register for the 4th EBNEO conference, Nov 2017, Hyderabad
• 07: Annual Meeting 10 May

April 2017

• 05: Antenatal Betamethasone for Women at Risk for Late Preterm Delivery Reduces the Rate of Neonatal Respiratory Complications
• 04: Is High-Flow Nasal Cannula Noninferior to Nasal CPAP for the Initial Management of Preterm Infants?

February 2017

• 28: Does dextrose gel prevent treatment failure in infants with neonatal hypoglycemia?
• 10: Annual Report and Fiscal Report for 2016
• 03: Admission hypo- and hyperthermia are associated with increased mortality and morbidity in very preterm infants
• 03: Probiotics for prevention of suspected sepsis in low birthweight infants
• 03: Oxygen-Saturation Targets in Extremely Preterm Infants
• 03: Predictors for Referral-Warranted ROP

December 2016

• 08: The 4th EBNEO conference 10-12 November, India (4)

October 2016

• 16: Updated author instructions

September 2016

• 30: Partnership with Acta Paediatrica
• 28: EBNEO 2015 Conference Video Series: Barbara Schmidt Presents “Making Sense of the Recent Oxygen Saturation Targeting Trials in Extremely Preterm Infants”
• 16: Individual memberships free of charge!
• 16: Videos from Evidence Live

August 2016

• 30: Back to the basics of EBM
• 04: Annual Meeting 14/9

July 2016

• 18: EBNEO 2015 Conference Video Series: Juliann DiFiore presents “Oxygen Saturation Signal: Use it Wisely” (2)

June 2016

• 29: EBNEO partner up with Cochrane and Vermont Oxford Network
• 27: EBNEO 2015 Conference Video Series: Mikael Norman presents “What We Have Learned from the Swedish Databases of Outcomes of ELBW Infants”
• 21: EBNEO is partner of ANCC2016
• 13: EBNEO 2015 Conference Video Series: Sara DeMauro presents “An Evidence Based Approach to Tracheostomy for the Chronically Ventilated Newborn”

May 2016

• 12: Annual reports 2015
• 02: EBNEO 2015 Conference Video Series: Elaine Boyle presents “Late and Moderate Prematurity: Evidence to Guide Practice” (2)

April 2016

• 28: Survey on the EBNEO email service
• 25: EBNEO 2015 Conference Video Series: Jennifer Culhane presents “Social Determinants of Prematurity”
• 13: Renew your EBNEO membership for 2016 (2)
• 11: EBNEO 2015 Conference Video Series: Dmitry Dukhovny presents “Improving Value in Neonatal Care Through Economic Evaluations Alongside Randomized Trials”

March 2016

• 08: Renewal of memberships (8)
• 07: EBNEO 2015 Conference Video Series: Roger Soll Presents “New Wrinkles on Meta-Analysis”

February 2016

• 22: Breastfeeding and Outcome
• 16: EBNEO 2015 Conference Video Series: Nigel Paneth presents “The Composite Outcome Dilemma in Newborn Medicine” (2)
• 08: Does early treatment with inhaled budesonide prevent death or bronchopulmonary dysplasia in extremely preterm infants?

January 2016

• 25: EBNEO 2015 Conference Video Series: Gordon Guyatt presents “Making Sense of GRADE: What to do When There is No Randomized Evidence”

December 2015

• 29: New Years Greetings!
• 07: Does umbilical cord milking result in higher measures of systemic blood flow in preterm infants?
• 01: Does single mega-dose vitamin A in the early neonatal period reduce mortality during infancy in low- and middle-income countries?

November 2015

• 09: Oral paracetamol or oral ibuprofen to close the ductus arteriosus: both “work,” but do we know when to use them? (3)
• 05: Hypercapnia review rocketing on Twitter! Our comment field is also open!
• 02: Permissive hypercapnia in extremely-low-birthweight infants: how far should we go? (1)

October 2015

• 26: Is oral amoxicillin as safe and effective as intramuscular procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants (<2 months of age) with fast breathing when referral is not possible?

September 2015

• 30: Membership fee discounts
• 28: News from the Annual Business Meeting
• 21: Airway support during neonatal resuscitation: How effective is a laryngeal mask?

August 2015

• 31: Annual Business Meeting 2015
• 19: Statistics about us
• 03: Association of Early Versus Late Caffeine Administration on Neonatal Outcomes in Very Preterm Neonates

July 2015

• 20: Randomized Controlled Trial of Lactoferrin for Prevention of Sepsis in Peruvian Neonates Less than 2500g
• 06: Do probiotics or prebiotics alone or in combination reduce the incidence of NEC in very low birth weight (<1500 grams) infants?

June 2015

• 22: Cord stripping in preterm neonates (1)
• 09: Update on dates for abstracts and registration to the EBNEO conference
• 08: Longer treatment for symptomatic congenital cytomegalovirus infection may have only modest long-term benefits.
• 01: Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants (2)

May 2015

• 29: The growing footprint of EBNEO
• 25: Late Neuroimaging Predicts Neurodevelopmental Impairment at 18-22 Months in Preterm Infants Born at 24-27 Completed Weeks’ Gestation (1)
• 18: Repeat doses of antenatal betamethasone and risk factors for cardio-metabolic disease at early school age
• 14: Special welcome to the latest Institutional members
• 11: Re-feeding gastric residuals in extremely preterm infants (4)
• 04: Hypertension at late preterm gestation: deliver immediately or watch and wait? (2)

April 2015

• 27: Longer and deeper cooling for hypoxic ischemic encephalopathy in neonates does not reduce mortality
• 25: Join the EBNEO meetup at the #PASmeeting
• 20: Twin birth – planned vaginal delivery still standard of care (1)
• 15: Buzz on Twitter (1)
• 13: Delivering non-invasive positive pressure to prevent extubation failure in preterm infants: nasal CPAP remains the standard of care
• 10: EBNEO conference delegates are granted a free membership
• 06: Sustained lung inflation in extreme preterm infants (2)

March 2015

• 31: 50% discount for new institutional members
• 30: Establishing ventilation in the delivery room: T-piece resuscitator versus self-inflating bag
• 26: Socialize with EBNEO
• 23: Does fluconazole prophylaxis reduce the incidence of death or invasive candida infection in extremely preterm infants?
• 16: A randomized blinded trial to assess whether near infrared spectroscopy measures of cerebral saturation in infants <28 weeks gestation enables clinicians to maintain a defined cerebral oxygen target range
• 14: Become an EBNEO member

February 2015

• 18: Humidification and heating of inspired gas during delivery room stabilization improves admission temperature in preterm infants
• 13: Welcome to the 3rd EBNEO conference
• 13: International Society for Evidence-Based Neonatology – the re-launch of the EBNEO project (1)